Northampton-based Hampton Knight is set to be strengthened by the appointment of a new CEO who has joined the alcohol, drug and COVID-19 testing business with a brief to accelerate its growth by improving customer relationships, introducing new product ranges and building a strategy to enhance its core services. Scot Smith takes up his post this month and is ambitious for the future growth and development of Hampton Knight which is part of the Medigold Health Group.
Hampton Knight was founded in May 2000 and in 2020 added COVID-19 testing capabilities to its portfolio to help businesses combat the coronavirus pandemic.
Scot grew up in South Africa and moved to the UK twelve years ago where he lives with his family in Surrey. With more than 20 years’ experience in the healthcare sector, Scot was Managing Director for Capita PLC before joining Medigold Health when it acquired Capita’s Occupational Health division in 2014.
“I am delighted to have joined Hampton Knight at this exciting time in its history. The brand is well-respected amongst its client base and has a fantastic reputation for high quality and excellent customer service delivered with professionalism.
“Hampton Knight has responded with agility during the COVID-19 crisis and is now supporting businesses with PCR and Rapid Lateral Flow testing programmes enabling hundreds of organisations to protect their workforce and maintain business continuity at this critical time. Building on this success, I am keen to see Hampton Knight expand its capacity to support companies and their employees during this difficult period.”
Despite the current lockdown restrictions, Hampton Knight remains fully operational including for the delivery of its core alcohol and drug testing programmes. Scot Smith is concerned about the impact of the lockdown on the mental health and wellbeing of many people who continue to work from home and may experience the negative impact of isolation.
“There has never been a more important time to focus on your employees’ wellbeing. The increase in problem drinking and substance abuse during the pandemic has been well documented. It is really important that employers are cognisant of the impact that this trend could have on individuals while performing their duties at work and at home.
“Hampton Knight complements its drug and alcohol testing services with advice for businesses to set and review their policies, with relevant training and with help for employers to support individuals who have been identified as dependent on drugs or alcohol.”
Alex Goldsmith, CEO of Medigold Health said,
“We’re delighted with Scot’s appointment and are confident that he will be a key asset to the further development of the Hampton Knight brand.
“Building on his excellent track record, we are sure that Scot will deliver his ambitious plans for the business and boost the success of the Medigold Health Group as we move forward.”
To find out more about Hampton Knight’s alcohol and drug testing services, or its COVID-19 testing programme, call 0845 127 8888 or complete the web form.